| Literature DB >> 34295441 |
Jensen N Amens1, Gökhan Bahçecioglu1, Pinar Zorlutuna1,2,3,4.
Abstract
Breast cancer is one of the most common cancers in women, with the ability to metastasize to secondary organs, which is the main cause of cancer-related deaths. Understanding how breast tumors progress is essential for developing better treatment strategies against breast cancer. Until recently, it has been considered that breast cancer elicits a small immune response. However, it is now clear that breast tumor progression is either prevented by the action of antitumor immunity or exacerbated by proinflammatory cytokines released mainly by the immune cells. In this comprehensive review we first explain antitumor immunity, then continue with how the tumor suppresses and evades the immune response, and next, outline the role of inflammation in breast tumor initiation and progression. We finally review the current immunotherapeutic and immunoengineering strategies against breast cancer as a promising emerging approach for the discovery and design of immune system-based strategies for breast cancer treatment. © Biomedical Engineering Society 2021.Entities:
Keywords: Antitumor immunity; Breast cancer progression; Immune cells; Immune evasion; Immune suppression; Immunotherapy; Proinflammatory cytokines; immune engineering
Year: 2021 PMID: 34295441 PMCID: PMC8280260 DOI: 10.1007/s12195-021-00679-8
Source DB: PubMed Journal: Cell Mol Bioeng ISSN: 1865-5025 Impact factor: 3.337